{"id":"W2122865912","doi":"10.1161/01.cir.0000087447.12918.85","title":"Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction","year":2003,"lang":"en","type":"article","venue":"Circulation","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":320,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Heart Institute; University of Alberta","funders":"Alexion Pharmaceuticals; Procter and Gamble","keywords":"Medicine; Bolus (digestion); Myocardial infarction; Placebo; Percutaneous coronary intervention; Cardiology; Internal medicine; Anesthesia; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003272749,0.0002145523,0.0002986008,0.000273265,0.0001709434,0.00002980695,0.0001354943,0.0001222526,0.001179501],"category_scores_gemma":[0.00003507272,0.0002314774,0.0001306226,0.0002122091,0.00004958705,0.0002568638,0.00004385278,0.0001339616,0.0002853441],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003704548,"about_ca_system_score_gemma":0.00006886369,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002604435,"about_ca_topic_score_gemma":0.00005303831,"domain_scores_codex":[0.9979731,0.0006816835,0.000471797,0.0004585362,0.000102095,0.0003127264],"domain_scores_gemma":[0.9993138,0.00005148811,0.0001448284,0.0003364067,0.0001119852,0.0000414397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0005978993,0.0006023943,0.4395956,0.00002111485,0.0003345296,0.00002894127,0.001036932,0.000769764,0.5439835,0.001138956,0.000282345,0.01160804],"study_design_scores_gemma":[0.002510975,0.0004137987,0.9902044,0.00005731038,0.00005144709,0.0004047139,0.0004861816,0.00003541454,0.001500175,0.0003965282,0.003670806,0.0002682396],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953229,0.0005899062,0.0009220826,0.00007606752,0.0009713225,0.001298209,0.00005789462,0.00009381997,0.0006677494],"genre_scores_gemma":[0.9969947,0.00003998342,0.000055505,0.0002465124,0.00003429782,0.00007188906,0.002494522,0.0000245423,0.00003802004],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5506089,"threshold_uncertainty_score":0.9997336,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02034240525581782,"score_gpt":0.3012870588420645,"score_spread":0.2809446535862467,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}